Opioid Use Disorder clinical trials
254 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- GLP-1R Agonist Treatment for Opioid Use Disorder
- Outpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
- Injectable Buprenorphine in Prison: A Preference Trial
- A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- tDCS to Decrease Opioid Relapse (UH3)
- Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
- Better Experiences in Substance Treatment: A Brief Alcohol-focused Intervention Tailored for Patients in Opioid Agonist Treatment
- Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
- A Unique, Co-Designed Family-Based Therapy
- Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
- Ketamine for Opioid Use Disorder
- Adjunctive Cannabidiol for Recovery From Opioid Study
- Buprenorphine for Individuals in Jail
- Opioid Adherence and Support Through Innovative Texting Strategies
- Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
- Mindfulness-Based Ecological Momentary Intervention for Opioid Use Disorder and Chronic Pain
- Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
- Building Retention and Initiation Through Delivery of Peer-Guided Evidence-Based Practices
- Aim 2 - Conversations Can Save Lives: TALKing About Buprenorphine & Methadone for Opioid Use Treatment Initiation
- A Bundled Intervention
- Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)
- MDMA for Co-occurring PTSD and OUD After Childbirth
- Expanding the Youth Opioid Recovery Support (YORS) Intervention for MOUD Adherence to Adolescents With OUD
- Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department
- Sparrow Link Neuromodulation Device for Opioid Withdrawal Management in Hospitalized Adults With Opioid Use Disorder
- PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- A Clinical Trial Comparing Buprenorphine Formulations for High Potency Synthetic Opioid Use
- Ketamine Assisted Psychotherapy for Opioid Use Disorder
- Brief Digitally-Enhanced Intervention for Reducing Alcohol Use During MOUD
- Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
- High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
- Optimization of NIBS for Treatment of Addiction
- Cannabidiol in Opioid Use Disorder and Chronic Pain
- Ketones for Opioid Craving
- Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
- Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
- TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)
- Integrated Treatment for Opioid Use Disorder and PTSD
- Semaglutide for Helping Opioid Recovery
- Young Houston Emergency Opioid Engagement System
- Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD
- The Effect of Light Intervention on Recovery in Individuals With Opioid Use Disorder (OUD)
- Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use
- Assessing Optimal XRB Initiation Points in Jail
- Adaptive Decision Support for Addiction Treatment Master
- Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
- Psilocybin for Opioid Use Disorder (OUD)
- Clinical Trials of Multivalent Opioid Vaccine Components
- Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Opioid Use Disorder” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.